Literature DB >> 33094849

PReferentially expressed antigen in MElanoma (PRAME) expression in BRCA1-associated protein (BAP1)-inactivated melanocytic tumors and deep penetrating nevi: A pilot study.

Dan Rolando Lopez1, Jessica A Forcucci1, Heather O'Connor1, John C Maize1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33094849     DOI： 10.1111/cup.13905

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN： 0303-6987            Impact factor:   1.587


× No keyword cloud information.
  3 in total

1.  HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).

Authors:  Marco Grillini; Costantino Ricci; Vincenzo Pino; Silvia Pedrini; Michelangelo Fiorentino; Barbara Corti
Journal:  Appl Immunohistochem Mol Morphol       Date:  2022-01-01

Review 2.  Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study.

Authors:  Gerardo Cazzato; Katia Mangialardi; Giovanni Falcicchio; Anna Colagrande; Giuseppe Ingravallo; Francesca Arezzo; Giovanna Giliberti; Irma Trilli; Vera Loizzi; Teresa Lettini; Sara Scarcella; Tiziana Annese; Paola Parente; Carmelo Lupo; Nadia Casatta; Eugenio Maiorano; Gennaro Cormio; Leonardo Resta; Domenico Ribatti
Journal:  Genes (Basel)       Date:  2022-03-19       Impact factor: 4.096

Review 3.  Conventional and Atypical Deep Penetrating Nevus, Deep Penetrating Nevus-like Melanoma, and Related Variants.

Authors:  Pavandeep Gill; Phyu P Aung
Journal:  Biology (Basel)       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.